Literature DB >> 22628410

Evolutionary pathways in BRCA1-associated breast tumors.

Filipe C Martins1, Subhajyoti De, Vanessa Almendro, Mithat Gönen, So Yeon Park, Joanne L Blum, William Herlihy, Gabrielle Ethington, Stuart J Schnitt, Nadine Tung, Judy E Garber, Katharina Fetten, Franziska Michor, Kornelia Polyak.   

Abstract

BRCA1-associated breast tumors display loss of BRCA1 and frequent somatic mutations of PTEN and TP53. Here we describe the analysis of BRCA1, PTEN, and p53 at the single cell level in 55 BRCA1-associated breast tumors and computational methods to predict the relative temporal order of somatic events, on the basis of the frequency of cells with single or combined alterations. Although there is no obligatory order of events, we found that loss of PTEN is the most common first event and is associated with basal-like subtype, whereas in the majority of luminal tumors, mutation of TP53 occurs first and mutant PIK3CA is rarely detected. We also observed intratumor heterogeneity for the loss of wild-type BRCA1 and increased cell proliferation and centrosome amplification in the normal breast epithelium of BRCA1 mutation carriers. Our results have important implications for the design of chemopreventive and therapeutic interventions in this high-risk patient population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22628410      PMCID: PMC3738298          DOI: 10.1158/2159-8290.CD-11-0325

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  36 in total

1.  Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.

Authors:  Thomas A Buchholz; Xifeng Wu; Abu Hussain; Susan L Tucker; Gordon B Mills; Bruce Haffty; Sherry Bergh; Michael Story; Fady B Geara; William A Brock
Journal:  Int J Cancer       Date:  2002-02-10       Impact factor: 7.396

2.  Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.

Authors:  Hiroshi Haeno; Mithat Gonen; Meghan B Davis; Joseph M Herman; Christine A Iacobuzio-Donahue; Franziska Michor
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

3.  Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.

Authors:  C X Deng
Journal:  Mutat Res       Date:  2001-06-02       Impact factor: 2.433

4.  BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications.

Authors:  M Goggins; R H Hruban; S E Kern
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

5.  Association of BRCA1 with Rad51 in mitotic and meiotic cells.

Authors:  R Scully; J Chen; A Plug; Y Xiao; D Weaver; J Feunteun; T Ashley; D M Livingston
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

6.  Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.

Authors:  N Foray; V Randrianarison; D Marot; M Perricaudet; G Lenoir; J Feunteun
Journal:  Oncogene       Date:  1999-12-02       Impact factor: 9.867

Review 7.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities.

Authors:  L C Gowen; B L Johnson; A M Latour; K K Sulik; B H Koller
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

10.  The polyglutamylated lateral chain of alpha-tubulin plays a key role in flagellar motility.

Authors:  C Gagnon; D White; J Cosson; P Huitorel; B Eddé; E Desbruyères; L Paturle-Lafanechère; L Multigner; D Job; C Cibert
Journal:  J Cell Sci       Date:  1996-06       Impact factor: 5.285

View more
  64 in total

1.  Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.

Authors:  Christian Bowman-Colin; Bing Xia; Samuel Bunting; Christiaan Klijn; Rinske Drost; Peter Bouwman; Laura Fineman; Xixi Chen; Aedin C Culhane; Hong Cai; Scott J Rodig; Roderick T Bronson; Jos Jonkers; Andre Nussenzweig; Chryssa Kanellopoulou; David M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-08       Impact factor: 11.205

Review 2.  An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples.

Authors:  Vinod Kumar Yadav; Subhajyoti De
Journal:  Brief Bioinform       Date:  2014-02-20       Impact factor: 11.622

3.  Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.

Authors:  Pradip De; Yuling Sun; Jennifer H Carlson; Lori S Friedman; Brian R Leyland-Jones; Nandini Dey
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

4.  Tissue-specific tumor suppression by BRCA1.

Authors:  Eva Y-H P Lee; Serena Abbondante
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

5.  Genetic and phenotypic diversity in breast tumor metastases.

Authors:  Vanessa Almendro; Hee Jung Kim; Yu-Kang Cheng; Mithat Gönen; Shalev Itzkovitz; Pedram Argani; Alexander van Oudenaarden; Saraswati Sukumar; Franziska Michor; Kornelia Polyak
Journal:  Cancer Res       Date:  2014-01-21       Impact factor: 12.701

6.  Responsiveness of Brca1 and Trp53 Deficiency-Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in Mus musculus.

Authors:  Sahar J Alothman; Weisheng Wang; David S Goerlitz; Md Islam; Xiaogang Zhong; Archana Kishore; Redha I Azhar; Bhaskar V Kallakury; Priscilla A Furth
Journal:  Cancer Prev Res (Phila)       Date:  2017-03-10

7.  Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate Tumors.

Authors:  Brennan Decker; Danielle M Karyadi; Brian W Davis; Eric Karlins; Lori S Tillmans; Janet L Stanford; Stephen N Thibodeau; Elaine A Ostrander
Journal:  Am J Hum Genet       Date:  2016-04-14       Impact factor: 11.025

Review 8.  BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis.

Authors:  John J Krais; Neil Johnson
Journal:  Cancer Res       Date:  2020-08-03       Impact factor: 12.701

Review 9.  Genetically engineered mouse models of PI3K signaling in breast cancer.

Authors:  Sjoerd Klarenbeek; Martine H van Miltenburg; Jos Jonkers
Journal:  Mol Oncol       Date:  2013-02-11       Impact factor: 6.603

Review 10.  The mathematics of cancer: integrating quantitative models.

Authors:  Philipp M Altrock; Lin L Liu; Franziska Michor
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.